Early microcirculatory impairment during therapeutic hypothermia is associated with poor outcome in post-cardiac arrest children: A prospective observational cohort study  by Buijs, Erik A.B. et al.
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Aims  of the  study:  This  study  aimed  to evaluate  if the  microcirculation  is  impaired  during  and  after  thera-
peutic  hypothermia  (TH)  in children  with  return  of  spontaneous  circulation  after  cardiac  arrest  (CA)  and
to assess  if microcirculatory  impairment  predicts  mortality.  This  has  been  reported  for  post-CA  adults,
but  results  might  be different  for children  because  etiology,  pathophysiology,  and  mortality  rate  differ.
Methods: This  prospective  observational  cohort  study  included  consecutive,  non-neonatal  post-CA  chil-
dren  receiving  TH  upon  intensive  care  admission  between  June  2008  and  June  2012.  Also  included  were
gender-matched  and age-matched  normothermic,  control  children  without  cardiorespiratory  disease.
The buccal  microcirculation  was  non-invasively  assessed  with  Sidestream  Dark  Field  Imaging  at  the  start
of TH,  halfway  during  TH,  at the start  of  re-warming,  and  at normothermia.  Macrocirculatory,  respiratory,
and biochemical  parameters  were  also  collected.
Results: Twenty  post-CA  children  were  included  of whom  9 died.  During  hypothermia,  the  microcir-
culation  was impaired  in  the post-CA  patients  and  did not  change  over  time.  At normothermia,  the
core  body  temperature  and  the microcirculation  had  increased  and  no longer  differed  from  the  controls.
Microcirculatory  deterioration  was  associated  with  mortality  in the  post-CA  patients.  In particular,  the
microcirculation  was  more  severely  impaired  at TH  start  in the  non-survivors  than  in the survivors  – pos-
itive  predictive  value:  73–83,  negative  predictive  value:  75–100,  sensitivity:  63–100%,  and  speciﬁcity:
70–90%.
Conclusions:  The  microcirculation  is impaired  in  post-CA  children  during  TH  and more  severe  impairment
at  TH  start  was  associated  with  mortality.  After  the  stop  of TH, the microcirculation  improves  rapidly
irrespective  of  outcome.
© 2013  Elsevier  Ireland  Ltd.  All  rights  reserved.. IntroductionCardiac arrest (CA) in children is associated with a high mortal-
ty rate.1,2 In the children with return of spontaneous circulation
ROSC), signiﬁcant morbidity is often present and a post-cardiac
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ttp://dx.doi.org/10.1016/j.resuscitation.2013.10.024arrest syndrome (PCAS) develops.1–3 In view of its beneﬁcial effects
on outcome in post-CA adults and asphyxiated neonates, mild ther-
apeutic hypothermia (TH) has been clinically introduced in post-CA
children.4–7 A randomized trial in post-CA children is currently
ongoing.8 While the exact mechanism by which TH improves out-
come is unknown, multiple beneﬁcial effects have been suggested,
which include balancing of vasoactive mediators and normalizing
vasopermeability.9
TH should reduce the harmful PCAS effects while adequate
macrocirculation and microcirculation is ensured. The microcircu-
lation can now be visualized non-invasively at the bedside with
several techniques.10 These have revealed that in post-CA adults the
microcirculation was  decreased during TH and that microcircula-
tory impairment existed while macrocirculatory parameters were
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tivity, speciﬁcity, and positive and negative predictive value were
calculated. With the cut-off values, the association between micro-
circulatory impairment and disease severity was explored. For all98 E.A.B. Buijs et al. / Resu
naltered.11,12 Moreover, persistent microcirculatory impairment
as associated with mortality.11 This has also been reported for
hildren with distributive shock.13
It is not yet known, however, whether these ﬁndings also
pply to post-CA children. Extrapolating the ﬁndings in post-CA
dults to children is probably inappropriate because CA etiology,
ost-CA pathophysiology, and post-CA mortality rate differ.3,9,14
on-invasive microcirculatory monitoring might be particularly
aluable for children as the possibilities for invasive hemodynamic
onitoring are limited.15 Therefore, this study aimed to assess
hether the microcirculation is impaired during and after TH in
ost-CA children and to evaluate whether microcirculatory impair-
ent predicts mortality. We  hypothesized that microcirculatory
lterations would exist during TH and that the microcirculation
ould predict mortality after TH.
. Methods
.1. Study design and setting
This prospective observational cohort study included patients
dmitted to the intensive care unit (ICU) of a level III university chil-
ren’s hospital between June 2008 and June 2012. The local medical
thical review board approved the study. Parental informed con-
ent was obtained prior to the study start.
.2. Patients
Children eligible for inclusion were those aged between 28
ays and 18 years with post-CA ROSC who received TH after
dmission to the study site. The exclusion criteria were: denied
nformed consent, start of TH in a center other than the study
ite, and failure to induce TH within 12 h after admission. Patients
n whom only one microcirculatory measurement was  done due
o logistic reasons were also excluded. Age-matched and gender-
atched normothermic children without cardiorespiratory disease
ho were hospitalized for minor, elective surgery served as con-
rols.
.3. Data collection
The modiﬁed Utstein reporting templates were followed where
ossible.16 Data were obtained within 12 h after the start of
H (T0), at 12–24 h after TH start (T1), within 12 h after start-
ng re-warming (T2), and at normothermia (T3). The primary
ndpoint was ICU survival. Data were obtained once in the con-
rols.
.3.1. Microcirculatory perfusion
The microcirculation was studied using Sidestream Dark Field
maging (MicroVision Medical, Amsterdam, the Netherlands).17 At
hree sites in the buccal mucosa, the microcirculation was  mea-
ured according to the guidelines.18 To avoid pressure artifacts, we
dhered to the standard operating procedure as published by Trze-
iak et al.19 Blinded, randomized video sequences were analyzed
fﬂine using dedicated software (Automated Vascular Analysis 3.0,
cademic Medical Centre, Amsterdam, the Netherlands). Total ves-
el density (TVD), perfused vessel density (PVD), proportion of
erfused vessels (PPV), microvascular ﬂow index (MFI), and het-
rogeneity index (HI) were calculated for small (S; Ø ≤ 10 m)
nd non-small vessels (NS; Ø 11–100 m)  according to the
uidelines.13,18,20,21 HI was calculated as the difference between
he highest and the lowest quadrant score that is then divided by
he mean score of all quadrants for one measurement. For all other
cores, the mean of the video sequences per measurement wason 85 (2014) 397–404
taken. The inter-observer variability between two raters was deter-
mined for all microcirculatory parameters using video sequences
obtained for the current (n = 60, 19%) and for another study (n = 60,
19%). The Spearman’s rank correlation coefﬁcient ranged from
0.533 to 0.932 (all p-values < 0.001; mean  = 0.768), the intra-class
correlation coefﬁcient from 0.565 to 0.869 (all p-values < 0.001;
mean  = 0.750).
2.3.2. Demographic and time-dependent parameters
Patient demographics were collected together with core body
temperature, disease severity measures – the vasopressor score
(VP-score), the Pediatric cerebral performance category scale
(PCPC) at ICU discharge, and the Pediatric logistic organ dysfunction
score (PELOD) at ICU day one and two-, macrocirculatory parame-
ters, peripheral capillary reﬁll time (pCRT), respiratory parameters,
and biochemical parameters. The VP-score, PCPC score, and PELOD
score, respectively serving as measures for cardiovascular, cere-
bral, and overall disease severity, were determined as previously
described.22–24
2.4. Hospital treatment protocol
TH – rectal core body temperature 32.0–34.0 ◦C – was induced
as soon as possible after admission using extracorporeal blankets
(Blanketrol III, Cincinnati Sub Zero, Cincinnati, USA). Com-
plementary intracorporeal cooling was applied if necessary.
According to protocol, all children who received advanced Pedi-
atric life support received TH. During TH, patients received
continuous sedation (midazolam, 50–1000 mcg  kg−1 h−1, mor-
phine, 5–30 mcg  kg−1 h−1, clonidine, 0.20–1.00 mcg kg−1 h−1,
and/or propofol, 1–8 mg  kg−1 h−1) and neuromuscular block-
ade (vecuronium, 40–100 mcg  kg−1 h−1 and/or rocuronium,
300–700 mcg  kg−1 h−1) if necessary. After 24 h, patients were
re-warmed – 0.25 ◦C h−1 – to normothermia – rectal core body
temperature 36.5–37.5 ◦C. To keep MABP within age-appropriate
normal range, ﬂuid resuscitation and cardiovascular drug support
were started at the discretion of the attending intensivist. Ventila-
tor settings were set to achieve normoxia (paO2 12.0–13.3 kPa) and
normocapnia (pCO2 4.0–6.4 kPa). Patients with refractory respi-
ratory failure despite maximal conservative treatment received
extracorporeal membrane oxygenation (ECMO).
2.5. Statistical analysis
Continuous data are presented as median (IQR); discrete data
as numbers (%). The microcirculatory data were analyzed in two
steps. First, differences over time were assessed using mixed effects
models with time as single parameter. Linearity was assumed for
all models except MFI  NS. In the case of overall differences, sub-
tests between time points were performed. Second, the relation
between outcome and the microcirculation was  assessed with non-
parametric tests and through joint modeling – which incorporates
both time and outcome as covariate thereby taking into account
both the longitudinal and survival effects.25 If relevant, the area
under the curve (AUC) of the receiver operating characteristic
(ROC) was  determined. Cut-off values were identiﬁed and sensi-other data only step one was performed. Cases were compared
to controls using non-parametric tests. Statistics were calculated
using IBM SPSS or R statistics 2.15.2. A p-value < 0.050 was  consid-
ered statistically signiﬁcant.
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Table  1
The baseline patient characteristics. Data are shown for the entire cohort and for the survivors and non-survivors separately.
Total
N = 20
Survivors
N = 11
Non-survivors
N = 9
p-Value
Male gender, n (%) 15 (75) 10 (91) 5 (56) 0.127
Out-of-hospital CA, n (%) 17 (85) 10 (91) 7 (78) 0.566
Witnessed CA, n (%) 19 (95) 10 (91) 9 (100) 1.000
Bystander CPR, n (%) 12 (60) 6 (67) 6 (75) 1.000
Time  ﬁrst CPR – ROSC in min, median (IQR) 15 (30) 15 (25) 20 (39) 0.818
First  monitored rhythm shockableA, n (%) 4 (20) 4 (40) 0 (0) 0.087
First  admission to another hospital, n (%) 2 (10) 0 (0) 2 (22) 0.189
Age  at ICU admission in y, median (IQR) 2.3 (10.6) 1.9 (11.6) 2.8 (8.9) 0790
Weight at ICU admission in kg, median (IQR) 13.0 (31.3) 13.0 (38.3) 13.0 (24.0) 0.675
Time  ICU admission – start TH in h, median (IQR) 0 (6) 4 (7) 0 (0) 0.009
Hypothermic at ICU admission, n (%) 11 (55) 4 (36) 7 (78) 0.092
First  recorded core body temperature in ◦C, median (IQR) 33.7 (2.3) 35.0 (2.8) 33.4 (2.1) 0.057
PELOD day 1, median (IQR) 33 (10) 32 (10) 33 (14) 0.298
PELOD  day 2, median (IQR) 32 (11) 31 (19) 32 (11) 0.331
Absent LPLR at start TH, n (%) 4 (20) 0 (0) 4 (50) 0.023
Fluid  balance day 1 in ml  kg−1 d−1, median (IQR) 2.4 (3.5) 2.7 (3.9) 2.1 (3.0) 0.849
Fluid  balance day 2 in ml  kg−1 d−1, median (IQR) 1.5 (2.2) 0.5 (2.2) 2.3 (1.9) 0.138
ECMO, n (%) 3 (15) 2 (18) 1 (11) 1.000
PCPC  at ICU discharge ≤ 2, n (%) 6 (30) 6 (55) 0 (0) NA
Length of ICU stay in days, median (IQR) 7.6 (7.1) 10.3 (25.7) 4.8 (7.9) 0.030
Diagnosis, n (%)
- Cardiac 9 (45) 6 (55) 3 (33) 0.406
-  Respiratory 11 (55) 5 (45) 6 (67)
Cause  of death, n (%)
-  Cardiac 2 (10) – 2 (10) NA
-  Respiratory 1 (5) – 1 (5)
-  Cerebral 6 (30) – 6 (30)
Categorical variables are presented as n (%), continuous variables as median (IQR). Differences assessed using non-parametric tests. CA: cardiac arrest, CPR: cardiopulmonary
resuscitation, ECMO: extracorporeal membrane oxygenation, h: hours, IQR: interquartile range, LPLR: left pupillary light reﬂex, min: minutes, ml  kg−1 d−1: milliliter per
kilogram per day, NA: not assessed, PCPC: pediatric cerebral performance category scale, PELOD: pediatric logistic organ dysfunction score, ROSC: return of spontaneous
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A All shockable rhythms were due to ventricular ﬁbrillation.
. Results
During the study period 55 patients with ROSC after CA were
dmitted to our ICU who received TH. Of those 55 eligible patients,
3 (42%) were excluded because of denied consent and 12 (22%)
ecause of logistic reasons. Twenty children were included who
eceived TH at the study site. These patients did not differ from the
xcluded patients with regards to gender, out-of-hospital CA, sur-
ival rate, and percentage of patients with primary cardiac disease.
Table 1 shows the baseline characteristics of the included
atients. In 9 (45%) patients, CA was caused by primary cardiac
isease – i.e., cardiomyopathy (n = 4), cardiac arrhythmias (n = 3),
ongenital cardiac anomaly (n = 1), and ALTE (n = 1). In the other
1 patients, CA was caused by primary respiratory failure – i.e.,
ubmersion (n = 5), infectious respiratory disease (n = 2), neuro-
uscular disorder (n = 1), aspiration (n = 1), tracheomalacia (n = 1),
nd hanging (n = 1).
Nine (45%) post-CA children died in the ICU. The causes of death
ere hypoxic–ischemic brain injury (n = 6), refractory cardiac fail-
re (n = 2), and refractory respiratory failure (n = 1). In two  out of
he six patients with brain injury, the direct cause of death was
ncontrollable intracranial pressure increments. In the four oth-
rs, continuation of therapy was futile as they fulﬁlled the criteria
f brain death. Two (22%) non-survivors did not reach normother-
ia. Three patients, one non-survivor, received ECMO. In 6 (55%)
ut of the 11 survivors the PCPC was ≤2, indicating that at ICU
ischarge they had, at worst, mild neurologic deﬁcits and that
hey were conscious, alert, and deemed capable of age-appropriate
nteractions. The median ﬁrst measured body temperature of the
on-survivors tended to be lower than that of the survivors. The
edian time between admission and start of TH was shorter for the
on-survivors. More non-survivors than survivors had an absent
upillary reﬂex at the start of TH.The 20 control patients without cardiorespiratory failure were
all admitted to a surgical ward for minor, elective surgery–i.e.,
abdominal (n = 7), urogenital (n = 5), craniofacial (n = 4), orthopedic
(n = 3), and thoracic (n = 1).
3.1. Macrocirculatory, respiratory, and biochemical parameters
over time
Table 2 depicts the macrocirculatory, respiratory, and bio-
chemical parameters during and after TH. Apart from core body
temperature, the median values for macrocirculatory and respi-
ratory parameters were all within the normal range. Biochemical
abnormalities for pH, BE, and arterial lactate were manifested pre-
dominantly at the start of TH, while Hb, Ht, and CRP were abnormal
predominantly at normothermia.
During TH the core body temperature was below 34.0 ◦C and it
remained unaltered. At normothermia the median (IQR) core body
temperature was signiﬁcantly higher than before: 37.0 (0.3) ◦C.
MABP, arterial saturation, MAP, pCO2, and the VP-score did not
change over time. BE and pH improved halfway TH and remained
improved at normothermia. As of the start of re-warming, pO2 and
arterial lactate improved as well. CRP increased while Ht decreased.
Hb was  lower at normothermia and HR increased.
3.2. The microcirculation over time
The microcirculatory parameters are shown in Fig. 1 and Table 3.
Mixed effects models indicated that all microcirculatory parame-
ters except TVD NS changed over time. Subtests for the parameters
with an overall difference showed that none improved during TH.
At the start of re-warming, all parameters except TVD S and HI S
were improved. At normothermia, all microcirculatory parameters
except PVD NS and PPV S were improved.
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Table  2
The macrocirculatory, respiratory, and biochemical parameters in the post-cardiac arrest children and the normothermic, healthy controls.
T0 T1 T2 T3 c0
N  = 18 N = 18 N = 19 N = 18 N = 20
Time to start TH in hoursA 3.6 (4.2) 15.6 (4.4) 28.9 (6.4) 43.4 (8.7) –
Core  body temperature in ◦C 33.4 (1.6)b 33.8 (1.6)b 33.9 (1.1)b 37.0 (0.3)a 36.9 (0.3)
Vasopressor score 0 (13)b 8 (22)b 10 (20)b 9 (26)b 0 (0)
Heart  rate in bpm 125 (45) 110 (56) 123 (63) 131 (51)a 130 (50)
MABP  in mm Hg 60 (30) 64 (19) 68 (28) 66 (23) 67 (18)
pCRT  in N < 3 s/N ≥ 3 s 1/16 2/15 3/15 6/15 –
MAP  in cm H2O 14 (7) 15 (10) 14 (5) 14 (6) –
Arterial  saturation in % 98 (2) 99 (2) 97 (2) 97 (3) –
pH  7.27 (0.32) 7.34 (0.12)a 7.34 (0.09)a 7.38 (0.11)a –
pO2 in kPa 14.8 (6.4) 13.8 (8.9) 11.4 (5.0)a 11.5 (5.5)a –
pCO2 in kPa 5.1 (2.1) 5.0 (1.2) 5.5 (0.9) 5.1 (1.6) –
Base  excess in mmol  L−1 −10 (8) −5 (4)a −4 (4)a −2 (3)a –
Arterial  lactate in mmol L−1 2.8 (5.8) 3.4 (4.5) 2.4 (2.4)a 1.5 (0.9)a –
C-reactive protein in mg  L−1 1 (5) 23 (51) 80 (78)a 73 (85)a –
Hemoglobin in mmol L−1 7.1 (1.0) 7.1 (2.5) 6.6 (1.5) 6.3 (1.5)a –
Hematocrit in L L−1 0.34 (0.07) 0.35 (0.08) 0.31 (0.05)a 0.30 (0.05)a –
All data are presented as median (IQR), except pCRT which is in n (%).
a Indicates change over time from T0 to T3 using mixed effects models and sub-tests.
b Indicates difference with c0 using non-parametric tests.
T0: at TH start, T1: halfway during TH, T2: at re-warming start T3: at normothermia in post-cardiac arrest children, c0: normothermic, healthy controls. Bpm: beats per
minute, cmH2O: centimeter water, kPa: kilopascal, L L−1: liter per liter, MABP: mean arterial blood pressure, MAP: mean airway pressure, mg L−1: milligram per liter, mmHg:
m −1 l time, ◦
P
l
n
F
i
(
hillimeter mercury, mmol L : millimoles per liter, pCRT: peripheral capillary reﬁlIn comparison to the normothermic control patients, TVD S,
VD S, PPV NS, PPV S, MFI  NS, MFI  S, HI NS, and HI S were all
ower during TH in the post-CA patients, while HR or MABP did
ot differ (Tables 2 and 3). At normothermia, the microcirculatory
ig. 1. Boxplots showing the microcirculatory parameters perfused vessel density (A), p
ndex  (D) for non-small (10 m ≤ Ø < 100 m)  and small (Ø < 10 m)  vessels in post-car
n  = 20; obliquely striped boxplots). T0: at TH start, T1: halfway during TH, T2: at re-warm
ealthy  controls. †  Indicates change over time from T0 to T3 using mixed effects models,  s: seconds, TH: therapeutic hypothermia, C: degrees Celsius.parameters in the post-CA patients did no longer differ from those
in the controls. Signiﬁcant correlations – range : 0.25–0.45 –
existed between core body temperature and PVD S, PPV NS, PPV
S, MFI  NS, MFI  S, and HI S (Fig. 2).
roportion of perfused vessels (B), microvascular ﬂow index (C), and heterogeneity
diac arrest children (n = 20; blank boxplots) and normothermic, healthy controls
ing start T3: at normothermia in post-cardiac arrest children, c0: normothermic,
* indicates difference with c0 using non-parametric tests.
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Table 3
The microcirculatory parameters total vessel density (TVD), perfused vessel density (PVD), proportion of perfused vessels (PPV), microvascular ﬂow index (MFI), and heterogeneity index (HI) for non-small (10 m ≤ Ø < 100 m)
and  small (Ø < 10 m) vessels in post-cardiac arrest children and normothermic, healthy controls.
T0 T1 T2 T3 c0
Whole group Whole group Whole group Whole group Whole group
Survivors Non-survivors Survivors Non-survivors Survivors Non-survivors Survivors Non-survivors
N  = 10 N = 8 N = 10 N = 8 N = 10 N = 9 N = 11 N = 7 N = 20
TVD non-small in n mm−1 7.0 (3.2) 8.0 (3.1) 8.0 (2.7)b 7.5 (3.0) 6.8 (1.9)
7.2  (1.8) 5.3 (3.3) 8.7 (2.7) 6.4 (3.5) 7.7 (2.8) 8.5 (3.1) 6.7 (3.6) 7.9 (1.9) –
PVD  non-small in n mm−1 6.4 (2.8) 7.2 (2.9) 7.8 (2.5)a,b 7.4 (3.0) 6.5 (2.1)
6.8  (2.6)c 4.3 (2.6)c 8.4 (2.4) 6.3 (3.8) 7.5 (2.7) 8.5 (2.9) 6.6 (3.8) 7.8 (2.1) –
PPV  non-small in % 92 (19)b 96 (9) 98 (3)a 99 (2)a 97 (6)
94  (11)c 83 (19)c 97 (5) 92 (20) 98 (3) 99 (3) 99 (2) 99 (1) –
MFI  non-small in au 2.62 (0.49)b 2.92 (0.46)b 3.00 (0.06)a 3.00 (0.00)a 3.00 (0.05)
2.74  (0.41)c 2.38 (0.64)c 2.96 (0.34) 2.72 (0.96) 3.00 (0.00)c 2.94 (0.17)c 3.00 (0.00) 3.00 (0.00) –
HI  non-small in au 0.38 (1.04)b 0.34 (0.56)b 0.00 (0.34)a 0.00 (0.35)a 0.00 (0.34)
0.36  (0.91) 0.99 (1.24) 0.17 (0.37) 0.37 (0.86) 0.00 (0.35) 0.00 (0.35) 0.00 (0.00) 0.00 (0.38) –
TVD  small in n mm−1 7.4 (3.8)b 7.2 (4.7)b 8.1 (3.0) 9.2 (3.9)a 9.7 (2.8)
7.7  (4.4) 7.4 (3.1) 9.0 (5.8) 6.7 (2.4) 7.8 (2.9) 8.3 (3.7) 9.1 (2.3) 9.3 (4.5) –
PVD  small in n mm−1 6.2 (4.6)b 6.5 (5.2)b 7.7 (2.8)a,b 9.0 (3.3)a 9.6 (2.9)
7.1  (5.2) 5.6 (2.7) 8.9 (5.8) 5.7 (3.7) 7.5 (2.6) 8.2 (3.7) 9.1 (2.3) 8.9 (4.8) –
PPV  small in % 86 (27)b 92 (21)b 97 (5)a 99 (5) 99 (3)
91  (14) 70 (28) 94 (11) 90 (29) 98 (4) 95 (5) 99 (5) 98 (5) –
MFI  small in au 2.56 (0.88)b 2.92 (0.58)b 3.00 (0.08)a 3.00 (0.00)a 3.00 (0.00)
2.72  (0.30)c 2.08 (1.13)c 2.96 (0.21) 2.79 (1.08) 3.00 (0.08) 3.00 (0.17) 3.00 (0.00) 3.00 (0.00) –
HI  small in au 0.57 (1.42)b 0.34 (0.93)b 0.00 (0.35)b 0.00 (0.35)a 0.00 (0.00)
0.37  (1.21) 1.24 (1.29) 0.17 (0.46) 0.36 (1.60) 0.00 (0.53) 0.00 (0.35) 0.00 (0.34) 0.00 (0.38) –
Data are presented in median (IQR) for the whole cohort (top line) as well as the post-cardiac survivors and non-survivors (bottom line).
a Indicates change over time from T0-T3 using mixed effects models and sub-tests.
b Indicates difference with c0 using non-parametric tests.
c Indicates difference between survivors and non-survivors using non-parametric tests.
T0: at TH start, T1: halfway during TH, T2: at re-warming start T3: at normothermia in post-cardiac arrest children, c0: normothermic, healthy controls.
402 E.A.B. Buijs et al. / Resuscitati
Fig. 2. Boxplots showing the microcirculatory parameters non-small perfused
vessel density (A), non-small proportion of perfused vessels (B), non-small
microvascular ﬂow index (C), and small microvascular ﬂow index (D) at the start
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iated neonates.4–7 Yet, non-clinical studies indicate that TH inf  hypothermia in survivors (n = 11; blank box plots) and non-survivors (n = 9;
bliquely striped box plots). Differences assessed using non-parametric tests.
.3. Microcirculatory impairment and outcome
At the start of hypothermia, PVD NS, PPV NS, MFI  NS, and MFI
 were lower in the non-survivors than in the survivors (Fig. 1,
able 3). The AUC of the ROC curves was for all four parameters 0.84
nd the best cut-off points for TVD NS, PVD NS, MFI  NS, and MFI  S
t TH start were estimated at 4.9 crossing mm−1, 92%, 2.68 au, and
.56 au, respectively (Table 4, Supplemental Fig. 1). With these cut-
ff values, sensitivity ranged from 63 to 100% and speciﬁcity ranged
rom 70 to 90%. The positive and negative predictive value for mor-
ality at ICU discharge ranged from 73 to 83% and from 75 to 100%,
espectively. Joint modeling indicated that for every unit increase
n PVD NS and MFI  S over time – i.e. not only at the start of hypother-
ia, but also thereafter-, the mortality risk decreased by 5.3 and by
.1, respectively. For the other microcirculatory parameters, there
as no association with mortality over time.
At TH start, the cut-off values according to vessel size – TVD NS,
VD NS, and MFI  NS vs. MFI  S – then served to stratify the dis-
ase severity measures arterial lactate over time, VP-score over
ime, PELOD at day one and two of ICU admission, and PCPC at
CU discharge (supplemental digital content Table 1). In this way
t became apparent that patients with microcirculatory deteriora-
ion in the non-small vessels – i.e., TVD NS, PVD NS, and MFI  NS had higher arterial lactate levels at normothermia; had higher
P-scores halfway during TH, at the start of re-warming, and at nor-
othermia; and had higher a PCPC score at ICU discharge. Likewise,on 85 (2014) 397–404
patients with lower MFI  S had microcirculatory deterioration had
a higher PCPC score at ICU discharge.
At the start of TH, neither the core body temperature nor the
macrocirculatory, respiratory, or biochemical parameters differed
between the survivors and the non-survivors, apart from BE which
was unfavorable for the non-survivors (supplemental digital con-
tent Table 2).
4. Discussion
This study demonstrates that the buccal microcirculation was
impaired during TH in post-CA children, while the cardiore-
spiratory parameters were relatively unaffected. After TH, the
microcirculation improved to a level comparable to normother-
mic  children without cardiorespiratory disease. Microcirculatory
impairment was associated with mortality in the post-CA patients.
In particular, at the start of TH, the microcirculation was  more
severely deteriorated in the non-survivors than in the survivors.
This study is the ﬁrst to describe that the buccal microcircu-
lation is altered during TH in post-CA children. Similar ﬁndings
have been reported for post-CA adults and perinatally asphyx-
iated neonates.11,12,26 The current study is unique in studying
the microcirculation shortly after re-warming. At this point, the
microcirculation had already improved substantially while neither
core body temperature, nor the macrocirculatory or respiratory
parameters had changed. This conﬁrms that in post-CA children
microcirculatory function cannot be estimated by macrocirculatory
parameters, as was  also reported for post-CA adults.11 Interestingly,
microcirculatory improvement coincided with improvements in
arterial lactate and pO2, while pCRT remained abnormal over time.
Microcirculatory impairment before and after TH predicted
mortality in post-CA adults, whereas we found the microcirculation
to be lower in non-survivors at TH start.11 Differences in etiology
can explain this discrepancy: all of the adults had primary cardiac
disease as opposed to 50% of the children.11 There are also patho-
physiologic differences: PCAS develops differently in children and
continuous post-CA macrocirculatory failure is less prominent.3
Accordingly, cerebral injury rather than cardiac disease is the pre-
dominant determinant for outcome in children.3,27–29 Our data
supported this as 75% of the non-survivors were brain death and
both HR and MABP were within the normal range throughout
follow-up.
In critically ill adults, therapy efﬁcacy and outcome could be
predicted by early microcirculatory monitoring.30,31 We show that,
next to mortality, microcirculatory impairment at TH start is asso-
ciated with cardiovascular disease severity and neurologic disease
severity later in time So, non-invasive microcirculatory monitoring
might be clinically valuable in post-CA children. For children – and
infants in particular – the possibilities for (invasive) cardiovascular
monitoring are limited.15
In the present study, microcirculatory impairment was asso-
ciated with poor outcome at TH start in particular. At this point,
pupillary reﬂexes were absent more often and BE, pH, and arterial
lactate either differed or tended to differ suggesting that the non-
survivors were in a worse clinical condition. Additionally, PCAS
is still in its early phase at TH start and includes amongst oth-
ers inﬂammation and continuous ischemia.3,9,32 Hypothetically,
both could have contributed to the microcirculatory impairment
in our patients.3,9,32 We,  however, did not measure SvO2, inter-
leukins, or complement factors. Furthermore, TH is acknowledged
to improve outcome in post-CA adults and perinatally asphyx-itself decreases the microcirculation.33 During TH, microcircula-
tory deterioration could either be an epiphenomenon or an active
mediator through which TH partly exerts its beneﬁcial effects. The
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Table  4
The value for predicting mortality in post-cardiac arrest children with the microcirculatory parameters non-small perfused vessel density (TVD), non-small proportion of
perfused vessels (PPV), non-small and small microvascular ﬂow index (MFI).
AUC (95%-CI) Cut-off
value
Sensitivity in %
(95%-CI)
Speciﬁcity in %
(95%-CI)
Positive predictive
value (95%-CI)
Negative predictive
value (95%-CI)
PVD non-small in n mm−1 0.84 (0.65–1.00) 4.9 63 (24–91) 90 (55–100) 83 (36–100) 75 (43–95)
PPV  non-small in n mm−1 0.84 (0.65–1.00) 92 100 (63–100) 70 (35–100) 73 (34–94) 100 (59–100)
MFI  non-small in au 0.84 (0.64–1.00) 2.68 100 (63–100) 70 (35–100) 73 (34–94) 100 (59–100)
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oMFI  small in au 0.84 (0.65–1.00) 2.56 88 (47–10
UC: area under the receiver operating characteristic, 95%-CI: 95% conﬁdence inter
atter would contrast our observation that microcirculatory impair-
ent relates to poor outcome. Thus, our results suggest that TH
mproves outcome by impacting enzymatic and metabolic pro-
esses predominantly.3,9,32
Although core body temperature did not differ at the time of
he microcirculatory measurements, we did observe that hypother-
ia  was more rapidly induced in the non-survivors and that the
rst recorded temperature tended to be lower. This was  observed
efore.34 Neither the underlying diagnoses, nor the number of
ear-drownings differed in our study and hospital protocol applied
o all patients. In contrast, our neurologic and biochemical mea-
urements suggest that the more rapidly induced hypothermia
ost likely resulted from the non-survivors’ poor clinical condition.
on-induced hypothermia occurs as often as hyperthermia and
onveys an increased mortality risk as well.35,36 Endogenous fac-
ors attributing to non-induced hypothermia include altered basal
etabolic rate, impaired cortisol release, hypothalamic tempera-
ure set-point alterations, vasoconstriction, and absent shivering.35
Absent pupillary reﬂexes and lower pH are independently asso-
iated with mortality in post-CA children.3,36 Future research
hould focus on the combination of parameters that best predict
oor outcome or monitor therapy efﬁcacy. Our study shows that
on-invasive microcirculatory monitoring could be considered as
ovariate in future studies, but also that the predictive accuracy of
icrocirculatory monitoring in post-CA children should be detailed
etter and that the functional role of the microcirculation during
CAS and TH should be elucidated.
.1. Limitations
Several limitations must be acknowledged. Above all, few data
egarding the period prior to ICU admission were available so it
s unclear to what extent the proceedings during the resuscitation
eriod biased our ﬁndings. Furthermore, the included cohort was
odest in size and quite heterogeneous. For instance, two patients
ere ﬁrst admitted to another hospital. Also, CPR time and lac-
ate levels were relatively short/low. Relatively many patients were
xcluded. Results should thus be interpreted cautionately, given
hat data were obtained only in the patients who  received TH at the
tudy site. Multicenter trials are therefore needed to substantiate
ur ﬁndings. Furthermore, owing to the observational design, our
ndings are associative rather than causal. Also, microcirculatory
onitoring was limited to the very early post-CA phase whereas
he follow-up for survival was longer. In addition, a reliable pre-
ypothermic microcirculatory assessment was not possible.
. Conclusions
In non-neonatal post-CA children, the microcirculation is
mpaired during TH and improves rapidly after TH discontinuation.
icrocirculatory impairment early after the start of TH is associ-
ted with poor outcome. Future studies should evaluate in greater
etail the accuracy by which microcirculatory monitoring predicts
utcome and whether it can be used to assess therapy efﬁcacy.
180 (44–97) 78 (40–97) 89 (52–100)
mm−1: number per millimeter, au: arbitrary units.
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